Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Brosjö O[au]:

Search results

Items: 1 to 50 of 103

1.

Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.

Saba KH, Cornmark L, Rissler M, Fioretos T, Åström K, Haglund F, Rosenberg AE, Brosjö O, Nord KH.

Genes Chromosomes Cancer. 2019 Oct;58(10):731-736. doi: 10.1002/gcc.22764. Epub 2019 May 15.

PMID:
31066955
2.

Soft-tissue fat tumours: differentiating malignant from benign using proton density fat fraction quantification MRI.

Skorpil M, Rydén H, Berglund J, Brynolfsson P, Brosjö O, Tsagozis P.

Clin Radiol. 2019 Jul;74(7):534-538. doi: 10.1016/j.crad.2019.01.011. Epub 2019 Apr 15.

PMID:
31000331
3.

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

Brodin BA, Wennerberg K, Lidbrink E, Brosjö O, Potdar S, Wilson JN, Ma L, Moens LN, Hesla A, Porovic E, Bernhardsson E, Papakonstantinou A, Bauer H, Tsagkozis P, von Sivers K, Wejde J, Östling P, Kallioniemi O, Stragliotto CL.

Br J Cancer. 2019 Feb;120(4):435-443. doi: 10.1038/s41416-018-0359-4. Epub 2019 Feb 12.

4.

Preoperative radiotherapy of soft-tissue sarcomas: surgical and radiologic parameters associated with local control and survival.

Tsagozis P, Brosjö O, Skorpil M.

Clin Sarcoma Res. 2018 Oct 5;8:19. doi: 10.1186/s13569-018-0106-x. eCollection 2018.

5.

Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years.

Hofvander J, Viklund B, Isaksson A, Brosjö O, Vult von Steyern F, Rissler P, Mandahl N, Mertens F.

Nat Commun. 2018 Sep 10;9(1):3662. doi: 10.1038/s41467-018-06098-0.

6.

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.

Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, Donati D, Kevric M, Brosjö O, Comandone A, Werner M, Monge O, Palmerini E, Berdel WE, Bjerkehagen B, Paioli A, Lorenzen S, Eriksson M, Gambarotti M, Tunn PU, Jebsen NL, Cesari M, von Kalle T, Ferraresi V, Schwarz R, Bertulli R, Kasparek AK, Grignani G, Krasniqi F, Sorg B, Hecker-Nolting S, Picci P, Reichardt P.

Tumori. 2018 Jan-Feb;104(1):30-36. doi: 10.5301/tj.5000696.

PMID:
29218692
7.

The effect of radiotherapy on fat content and fatty acids in myxoid liposarcomas quantified by MRI.

Skorpil M, Rydén H, Wejde J, Lidbrink E, Brosjö O, Berglund J.

Magn Reson Imaging. 2017 Nov;43:37-41. doi: 10.1016/j.mri.2017.07.005. Epub 2017 Jul 8.

PMID:
28698004
8.

Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones: The Scandinavian Sarcoma Group Experience.

Hesla AC, Tsagozis P, Jebsen N, Zaikova O, Bauer H, Brosjö O.

J Bone Joint Surg Am. 2016 Feb 3;98(3):199-210. doi: 10.2106/JBJS.O.00362. Erratum in: J Bone Joint Surg Am. 2016 Apr 6;98(7):e29.

PMID:
26842410
9.

Intra-Articular Synovial Sarcomas: Incidence and Differentiating Features from Localized Pigmented Villonodular Synovitis.

Nordemar D, Öberg J, Brosjö O, Skorpil M.

Sarcoma. 2015;2015:903873. doi: 10.1155/2015/903873. Epub 2015 Dec 24.

10.

Current Strategies for the Treatment of Aneurysmal Bone Cysts.

Tsagozis P, Brosjö O.

Orthop Rev (Pavia). 2015 Dec 28;7(4):6182. doi: 10.4081/or.2015.6182. eCollection 2015 Dec 28. Review.

11.

Femoral Metastasis from Penile Carcinoma: Report of 2 Cases.

Braumann L, Tsagozis P, Wedin R, Brosjö O.

Case Rep Urol. 2015;2015:583851. doi: 10.1155/2015/583851. Epub 2015 Oct 22.

12.

Reconstruction of metastatic acetabular defects using a modified Harrington procedure.

Tsagozis P, Wedin R, Brosjö O, Bauer H.

Acta Orthop. 2015;86(6):690-4. doi: 10.3109/17453674.2015.1077308. Epub 2015 Jul 28.

13.

Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register.

Tsagozis P, Bauer HC, Styring E, Trovik CS, Zaikova O, Brosjö O.

J Surg Oncol. 2015 Jun;111(8):951-6. doi: 10.1002/jso.23927. Epub 2015 Jun 3.

PMID:
26040651
14.

Reconstruction with modular megaprostheses for sarcomas of the lower extremity.

Tsagkozis P, Brosjö O, Bauer HC.

Orthopedics. 2015 May;38(5):e401-6. doi: 10.3928/01477447-20150504-57.

PMID:
25970367
15.

Giant hydatid cyst of the pelvis, femur and retroperitoneal space: surgical treatment with extended hemipelvectomy.

Tsagozis P, Brosjö O.

BMJ Case Rep. 2015 May 12;2015. pii: bcr2015209715. doi: 10.1136/bcr-2015-209715.

16.

RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts.

Hofvander J, Tayebwa J, Nilsson J, Magnusson L, Brosjö O, Larsson O, von Steyern FV, Domanski HA, Mandahl N, Mertens F.

Lab Invest. 2015 Jun;95(6):603-9. doi: 10.1038/labinvest.2015.50. Epub 2015 Apr 13.

17.

[Most musculoskeletal soft tissue tumors are benign].

Geijer M, Styring E, Brosjö O, Skorpil M.

Lakartidningen. 2014 Sep 17-23;111(38):1578-80. Review. Swedish.

18.

Treatment of an aggressive aneurysmal bone cyst with percutaneous injection of polidocanol: a case report.

Brosjö O, Tsagozis P.

J Med Case Rep. 2014 Dec 20;8:450. doi: 10.1186/1752-1947-8-450.

19.

Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.

Hofvander J, Tayebwa J, Nilsson J, Magnusson L, Brosjö O, Larsson O, Vult von Steyern F, Mandahl N, Fletcher CD, Mertens F.

Clin Cancer Res. 2015 Feb 15;21(4):864-9. doi: 10.1158/1078-0432.CCR-14-2399. Epub 2014 Dec 16.

20.

Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma.

Płaszczyca A, Nilsson J, Magnusson L, Brosjö O, Larsson O, Vult von Steyern F, Domanski HA, Lilljebjörn H, Fioretos T, Tayebwa J, Mandahl N, Nord KH, Mertens F.

Int J Biochem Cell Biol. 2014 Aug;53:475-81. doi: 10.1016/j.biocel.2014.03.027. Epub 2014 Apr 8.

PMID:
24721208
21.

Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.

Nord KH, Nilsson J, Arbajian E, Vult von Steyern F, Brosjö O, Cleton-Jansen AM, Szuhai K, Hogendoorn PC.

PLoS One. 2013 Nov 13;8(11):e80725. doi: 10.1371/journal.pone.0080725. eCollection 2013.

22.

Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts.

Brosjö O, Pechon P, Hesla A, Tsagozis P, Bauer H.

Acta Orthop. 2013 Oct;84(5):502-5. doi: 10.3109/17453674.2013.850013. Epub 2013 Oct 31.

23.

Integrative genome and transcriptome analyses reveal two distinct types of ring chromosome in soft tissue sarcomas.

Nord KH, Macchia G, Tayebwa J, Nilsson J, Vult von Steyern F, Brosjö O, Mandahl N, Mertens F.

Hum Mol Genet. 2014 Feb 15;23(4):878-88. doi: 10.1093/hmg/ddt479. Epub 2013 Sep 26.

PMID:
24070870
24.

Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor.

Mohajeri A, Tayebwa J, Collin A, Nilsson J, Magnusson L, von Steyern FV, Brosjö O, Domanski HA, Larsson O, Sciot R, Debiec-Rychter M, Hornick JL, Mandahl N, Nord KH, Mertens F.

Genes Chromosomes Cancer. 2013 Oct;52(10):873-86. doi: 10.1002/gcc.22083. Epub 2013 Jun 12.

PMID:
23761323
25.

Megaprosthetic reconstruction for periprosthetic or highly comminuted fractures of the hip and knee.

Lundh F, Sayed-Noor AS, Brosjö O, Bauer H.

Eur J Orthop Surg Traumatol. 2014 May;24(4):553-7. doi: 10.1007/s00590-013-1237-7. Epub 2013 May 21.

PMID:
23689913
26.

A benign vascular tumor with a new fusion gene: EWSR1-NFATC1 in hemangioma of the bone.

Arbajian E, Magnusson L, Brosjö O, Wejde J, Folpe AL, Nord KH, Mertens F.

Am J Surg Pathol. 2013 Apr;37(4):613-6. doi: 10.1097/PAS.0b013e31827ae13b.

PMID:
23480895
27.

[Hemicorporectomy can give life back].

Brosjö O, Bauer H, Ljung A, Schenck L, Ahlen J.

Lakartidningen. 2013 Jan 16-22;110(3):90-1. Swedish. No abstract available.

PMID:
23424986
28.

SNP array and FISH findings in two pleomorphic hyalinizing angiectatic tumors.

Mohajeri A, Kindblom LG, Sumathi VP, Brosjö O, Magnusson L, Nilsson J, Nord KH, Mertens F.

Cancer Genet. 2012 Dec;205(12):673-6. doi: 10.1016/j.cancergen.2012.10.008. Epub 2012 Nov 22.

PMID:
23177593
29.

Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.

Nord KH, Paulsson K, Veerla S, Wejde J, Brosjö O, Mandahl N, Mertens F.

Neoplasia. 2012 Sep;14(9):807-12.

30.

The MDM2 SNP309 G allele is not preferentially amplified in bone and soft tissue tumors.

Mertens F, Brosjö O, von Steyern FV, Nord KH, Mandahl N.

Cancer Genet. 2012 Sep;205(9):470-3. doi: 10.1016/j.cancergen.2012.06.001.

PMID:
22939400
31.

Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors.

Gebre-Medhin S, Nord KH, Möller E, Mandahl N, Magnusson L, Nilsson J, Jo VY, Vult von Steyern F, Brosjö O, Larsson O, Domanski HA, Sciot R, Debiec-Rychter M, Fletcher CD, Mertens F.

Am J Pathol. 2012 Sep;181(3):1069-77. doi: 10.1016/j.ajpath.2012.05.030. Epub 2012 Jul 13.

PMID:
22796436
32.

Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years.

Smeland S, Bruland OS, Hjorth L, Brosjö O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Björk O, Alvegaard TA.

Acta Orthop. 2011 Apr;82(2):211-6. doi: 10.3109/17453674.2011.566141. Epub 2011 Mar 24.

33.

Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.

Brune JC, Tormin A, Johansson MC, Rissler P, Brosjö O, Löfvenberg R, von Steyern FV, Mertens F, Rydholm A, Scheding S.

Int J Cancer. 2011 Jul 15;129(2):319-30. doi: 10.1002/ijc.25697. Epub 2010 Dec 1.

34.

Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone.

Gebre-Medhin S, Broberg K, Jonson T, Gorunova L, von Steyern FV, Brosjö O, Jin Y, Gisselsson D, Panagopoulos I, Mandahl N, Mertens F.

Cytogenet Genome Res. 2009;124(2):121-7. doi: 10.1159/000207516. Epub 2009 May 5.

PMID:
19420923
35.

Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.

Hallor KH, Staaf J, Bovée JV, Hogendoorn PC, Cleton-Jansen AM, Knuutila S, Savola S, Niini T, Brosjö O, Bauer HC, Vult von Steyern F, Jonsson K, Skorpil M, Mandahl N, Mertens F.

Clin Cancer Res. 2009 Apr 15;15(8):2685-94. doi: 10.1158/1078-0432.CCR-08-2330. Epub 2009 Mar 31.

36.

Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP.

Ahlén J, Enberg U, Larsson C, Larsson O, Frisk T, Brosjö O, Rosen A, Bäckdahl M.

Sarcoma. 2001;5(3):143-9. doi: 10.1080/13577140120048601.

37.

Diagnosis of high-grade osteosarcoma by radiology and cytology: a retrospective study of 52 cases.

Söderlund V, Skoog L, Unni KK, Bertoni F, Brosjö O, Kreicbergs A.

Sarcoma. 2004;8(1):31-6. doi: 10.1080/13577140410001679239.

38.

POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands.

Möller E, Stenman G, Mandahl N, Hamberg H, Mölne L, van den Oord JJ, Brosjö O, Mertens F, Panagopoulos I.

J Pathol. 2008 May;215(1):78-86. doi: 10.1002/path.2327.

PMID:
18338330
39.

Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype.

Bartuma H, Hallor KH, Panagopoulos I, Collin A, Rydholm A, Gustafson P, Bauer HC, Brosjö O, Domanski HA, Mandahl N, Mertens F.

Genes Chromosomes Cancer. 2007 Jun;46(6):594-606.

PMID:
17370328
40.

Tiling resolution array comparative genomic hybridization analysis of a fibrosarcoma of bone.

Hallor KH, Heidenblad M, Brosjö O, Mandahl N, Mertens F.

Cancer Genet Cytogenet. 2007 Jan 1;172(1):80-3.

PMID:
17175386
41.

Osteoid osteoma in a 1-year-old boy-a case report.

Ekström W, Söderlund V, Brosjö O.

Acta Orthop. 2006 Aug;77(4):686-8. No abstract available.

PMID:
16929450
42.

Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours.

Storlazzi CT, Brekke HR, Mandahl N, Brosjö O, Smeland S, Lothe RA, Mertens F.

J Pathol. 2006 Aug;209(4):492-500.

PMID:
16721726
43.

Prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas.

Mertens F, Strömberg U, Rydholm A, Gustafson P, Bauer HC, Brosjö O, Mandahl N.

J Clin Oncol. 2006 Jan 10;24(2):315-20. Epub 2005 Dec 5.

PMID:
16330667
44.

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G; Italian and Scandinavian Sarcoma Groups.

J Clin Oncol. 2005 Dec 1;23(34):8845-52. Epub 2005 Oct 24.

PMID:
16246977
45.

Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.

Ahlén J, Wejde J, Brosjö O, von Rosen A, Weng WH, Girnita L, Larsson O, Larsson C.

Clin Cancer Res. 2005 Jan 1;11(1):206-16.

46.

[Radiofrequency ablation an effective invasive treatment].

Skorpil M, Söderlund V, Brosjö O.

Lakartidningen. 2004 Nov 25;101(48):3899-901. Swedish. No abstract available.

PMID:
15631224
47.

Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.

Smeland S, Wiebe T, Böhling T, Brosjö O, Jonsson K, Alvegård TA.

Acta Orthop Scand Suppl. 2004 Apr;75(311):92-8. Review. No abstract available.

PMID:
15188671
48.

Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience.

Smeland S, Wiebe T, Brosjö O, Böhling T, Alvegård TA.

Acta Orthop Scand Suppl. 2004 Apr;75(311):87-91. Review. No abstract available.

PMID:
15188670
49.

Diagnostic procedures and surgical treatment of bone sarcomas. Experience from the Scandinavian Sarcoma Group and Karolinska Hospital.

Brosjö O, Bauer HC.

Acta Orthop Scand Suppl. 2004 Apr;75(311):57-61. No abstract available.

PMID:
15188666
50.

The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.

Panagopoulos I, Storlazzi CT, Fletcher CD, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosjö O, Rydholm A, Isaksson M, Mandahl N, Mertens F.

Genes Chromosomes Cancer. 2004 Jul;40(3):218-28.

PMID:
15139001

Supplemental Content

Loading ...
Support Center